Envoy Medical (NASDAQ:COCH) just reported results for the first quarter of 2024.
- Envoy Medical reported earnings per share of -32 cents. This was below the analyst estimate for EPS of -26 cents.
- The company reported revenue of $59,000.
- This was 41% worse than the analyst estimate for revenue of $100,000.